Clinical Trial Update: Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports that the Phase 2 trial evaluating cetuximab with chemotherapy and radiation for newly diagnosed stage III/IV head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED